BCL6-IN-11
BCL6-IN-11 is a potent inhibitor of the BCL6 BTB domain and a partial degrader of BCL6. BCL6-IN-11 inhibits the interaction between the BCL6 BTB domain and BCOR with an IC50 of 6 nM. BCL6-IN-11 can be used for research related to BCL6 degradation in diffuse large B-cell lymphoma (DLBCL).
For research use only. We do not sell to patients.
- CAS No.: 2230406-60-5
- Formula: C22H24Cl2N6O3
- Molecular Weight:491.37
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
BCL6 BTB domain 6 nM (IC50) |
In Vitro
BCL6-IN-11 (Comp 8) inhibits the interaction between the BCL6 BTB domain and the BCOR peptide in the biochemical ULight LOW assay, with an IC50 of 6 nM[1].
BCL6-IN-11 (5 μM; 90 min) induces partial degradation of BCL6 protein in SU-DHL-4 diffuse large B-cell lymphoma (DLBCL) cells, reducing its level by 52%[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SU-DHL-4
-
Concentration:5 μM
-
Incubation Time:90 min
-
Result:Reduced BCL6 protein levels by 52%.
Chemical Information
-
CAS No. 2230406-60-5
-
Molecular Weight 491.37
-
Formula C22H24Cl2N6O3
-
SMILES
CNC(COC1=CC2=CC(NC3=NC(N4CCC(CC4)Cl)=NC=C3Cl)=CC=C2N(C1=O)C)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)